Our novel, safe viral vector platform enables the fast generation of mono- or multivalent vaccines against infectious diseases and cancer. The application results in strong balanced B-/T-cell immune response without any adjuvant and without the necessity of vector virus multiplication. Multiple or p... Read more
This company has no teams yet
This company has no offices yet